DeepMed Research

Fudan University

🇨🇳China

Country: 🇨🇳China

Ownership: Private

Established: 1905-01-01

Employees: 1K

Market Cap: -

Website: http://www.fudan.edu.cn

Clinical Trials

Apatinib for Advanced Biliary Carcinoma

Phase 2

Conditions: Biliary Tract Neoplasms

Interventions: Drug: Apatinib

First Posted Date: 2018-02-09

Last Posted Date: 2018-02-09

Lead Sponsor: Fudan University

Target Recruit Count: 55

Registration Number: NCT03427242

Locations: 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China

Safety and Efficacy of Statins for Chinese Patients With Dyslipidemia

Phase 4

Conditions: Dyslipidemias

Interventions: Drug: Pitavastatin
Drug: Atorvastatin
Drug: Rosuvastatin

First Posted Date: 2018-02-01

Last Posted Date: 2018-02-01

Lead Sponsor: Fudan University

Target Recruit Count: 10000

Registration Number: NCT03418974

Locations: 🇨🇳
School of Public Health, Fudan University, Shanghai, Shanghai, China
🇨🇳
Heart Center of Peking University People's Hospital, Beijing, Beijing, China

Hypofractionated PBI After BCS for Low-risk Breast Cancer Patients

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Radiation: hypofractionated partial breast irradiation

First Posted Date: 2018-01-26

Last Posted Date: 2025-05-13

Lead Sponsor: Fudan University

Target Recruit Count: 220

Registration Number: NCT03411174

Locations: 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China

Maintenance Chemotherapy in High-metastatic Risk Nasopharyngeal Carcinoma Patients of N3 Stage

Phase 3

Conditions: Nasopharyngeal Carcinoma

Interventions: Drug: Gemcitabine
Radiation: standard chemoradiotherapy

First Posted Date: 2018-01-19

Last Posted Date: 2019-07-08

Lead Sponsor: Fudan University

Target Recruit Count: 360

Registration Number: NCT03403829

Locations: 🇨🇳
Fudan Universtiy Shanghai Cancer Centre, Shanghai, Shanghai, China

The Combination Chemotherapy of SIRIOX as First- or Second-Line Chemotherapy for Pancreatic Cancer

Phase 2

Conditions: Carcinoma, Pancreatic Ductal

Interventions: Drug: S1
Drug: Oxaliplatin
Drug: Irinotecan

First Posted Date: 2018-01-18

Last Posted Date: 2021-04-09

Lead Sponsor: Fudan University

Target Recruit Count: 65

Registration Number: NCT03403101

Locations: 🇨🇳
Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University, Shanghai, Shanghai, China
🇨🇳
Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University; 270 Dong An Road, Shanghai 200032, China, Shanghai, China

Apatinib in the Treatment of Metastatic Colorectal Cancer

Phase 2

Conditions: Colorectal Cancer

Interventions: Drug: Apatinib

First Posted Date: 2018-01-18

Last Posted Date: 2018-01-18

Lead Sponsor: Fudan University

Target Recruit Count: 33

Registration Number: NCT03403452

Locations: 🇨🇳
Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China

XELOX for 4 Months Versus 6 Months in Gastric Cancer (LOMAC)

Phase 3

Active, not recruiting

Conditions: Gastric Cancer

Interventions: Drug: Oxaliplatin
Drug: Capecitabine

First Posted Date: 2018-01-16

Last Posted Date: 2024-03-12

Lead Sponsor: Fudan University

Target Recruit Count: 1032

Registration Number: NCT03399110

Locations: 🇨🇳
Anhui Provincial Hospital, Hefei, Anhui, China
🇨🇳
First Affiliated Hospital of Wannan Medical College, Wuhu, Anhui, China
🇨🇳
Shenzhen People's Hospital, Shenzhen, Guangdong, China

and more 6 locations

Simultaneous Resection of Pancreatic Cancer and Liver Oligometastasis After Induction Chemotherapy

Phase 3

Recruiting

Conditions: Pancreatic Cancer
Surgery
Liver Metastases

Interventions: Procedure: Synchronous resection of primary pancreatic cancer and liver oligometastasis
Drug: Standard chemotherapy

First Posted Date: 2018-01-12

Last Posted Date: 2018-10-09

Lead Sponsor: Fudan University

Target Recruit Count: 300

Registration Number: NCT03398291

Locations: 🇨🇳
Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University, Shanghai, Shanghai, China

Onset of Labour Epidural Analgesia With Different Concentration Bupivacaine and Different Doses of Sufentanyl

Phase 4

Completed

Conditions: Pregnant Women Who Requested Epidural Analgesia in the Early Stage of Labor

Interventions: Drug: B1S10
Drug: B125S5
Drug: B1S5

First Posted Date: 2018-01-10

Last Posted Date: 2019-06-07

Lead Sponsor: Fudan University

Target Recruit Count: 56

Registration Number: NCT03395600

Locations: 🇨🇳
Ethics Committee of The Obstetrics and Gynecology Hospital, Fudan University,, Shanghai, China

Adjuvant Chemotherapy for High Risk Stage I Lung Adenocarcinoma

Phase 2

Recruiting

Conditions: Lung Neoplasms

Interventions: Drug: cisplatin plus pemetrexed

First Posted Date: 2017-12-21

Last Posted Date: 2023-07-20

Lead Sponsor: Fudan University

Target Recruit Count: 300

Registration Number: NCT03380468

Locations: 🇨🇳
Fudan University Cancer Center, Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy